These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27131395)

  • 1. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials.
    Millán J; Cicero AF; Torres F; Anguera A
    Clin Investig Arterioscler; 2016; 28(4):178-87. PubMed ID: 27131395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.
    Pirro M; Mannarino MR; Bianconi V; Simental-Mendía LE; Bagaglia F; Mannarino E; Sahebkar A
    Pharmacol Res; 2016 Aug; 110():76-88. PubMed ID: 27157250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.
    Affuso F; Ruvolo A; Micillo F; Saccà L; Fazio S
    Nutr Metab Cardiovasc Dis; 2010 Nov; 20(9):656-61. PubMed ID: 19699071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
    Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
    Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment.
    Pisciotta L; Bellocchio A; Bertolini S
    Lipids Health Dis; 2012 Sep; 11():123. PubMed ID: 22998978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
    Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
    J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial.
    Solà R; Valls RM; Puzo J; Calabuig JR; Brea A; Pedret A; Moriña D; Villar J; Millán J; Anguera A
    PLoS One; 2014; 9(8):e101978. PubMed ID: 25084280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus.
    Ruscica M; Gomaraschi M; Mombelli G; Macchi C; Bosisio R; Pazzucconi F; Pavanello C; Calabresi L; Arnoldi A; Sirtori CR; Magni P
    J Clin Lipidol; 2014; 8(1):61-8. PubMed ID: 24528686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO
    Cicero AFG; D'Addato S; Borghi C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.
    Barrios V; Escobar C; Cicero AF; Burke D; Fasching P; Banach M; Bruckert E
    Atheroscler Suppl; 2017 Feb; 24():1-15. PubMed ID: 27998714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
    Galletti F; Fazio V; Gentile M; Schillaci G; Pucci G; Battista F; Mercurio V; Bosso G; Bonaduce D; Brambilla N; Vitalini C; D'Amato M; Giacovelli G
    Lipids Health Dis; 2019 Mar; 18(1):66. PubMed ID: 30885221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipaemic nutraceutics: red yeast rice and Armolipid, berberine and bergamot.
    Kłosiewicz-Latoszek L; Cybulska B; Stoś K; Tyszko P
    Ann Agric Environ Med; 2021 Mar; 28(1):81-88. PubMed ID: 33775071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
    Mazza A; Lenti S; Schiavon L; Zuin M; D'Avino M; Ramazzina E; Casiglia E
    Adv Ther; 2015 Jul; 32(7):680-90. PubMed ID: 26202829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
    Marchitto N; Sindona F; Fabrizio A; Mauti M; Andreozzi S; Dalmaso S; Raimondi G
    Minerva Cardioangiol; 2018 Feb; 66(1):124-125. PubMed ID: 29264910
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
    De Castro-Orós I; Solà R; Valls RM; Brea A; Mozas P; Puzo J; Pocoví M
    PLoS One; 2016; 11(3):e0150785. PubMed ID: 27015087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
    Francini-Pesenti F; Beltramolli D; Dall'acqua S; Brocadello F
    Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
    Fogacci F; Grassi D; Rizzo M; Cicero AFG
    Phytother Res; 2019 Apr; 33(4):862-870. PubMed ID: 30632209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
    Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
    JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial.
    Landi F; Martone AM; Salini S; Zazzara B; Calvani R; Marzetti E; Nesci A; Di Giorgio A; Giupponi B; Santoro L; Santoliquido A
    Biomed Res Int; 2019; 2019():1970878. PubMed ID: 30723735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Armolipid Plus
    Cicero AFG; Kennedy C; Knežević T; Bove M; Georges CMG; Šatrauskienė A; Toth PP; Fogacci F
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.